<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Overall survival data from LUX-Lung 7 head-to-head trial of afatinib versus gefitinib presented at ESMO 2016	</title>
	<atom:link href="https://www.novumpr.nl/2016/10/10/overall-survival-data-from-lux-lung-7-head-to-head-trial-of-afatinib-versus-gefitinib-presented-at-esmo-2016/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2016/10/10/overall-survival-data-from-lux-lung-7-head-to-head-trial-of-afatinib-versus-gefitinib-presented-at-esmo-2016/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=overall-survival-data-from-lux-lung-7-head-to-head-trial-of-afatinib-versus-gefitinib-presented-at-esmo-2016</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Mon, 10 Oct 2016 07:37:41 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
</channel>
</rss>
